Cellebrite DI (CLBT) Total Liabilities (2020 - 2025)

Cellebrite DI's Total Liabilities history runs 6 years deep, the most recent figure standing at $454.5 million for Q4 2025.

• On a quarterly basis, Total Liabilities rose 28.2% year-over-year to $454.5 million in Q4 2025; TTM through Dec 2025 was $454.5 million, a 28.2% increase from a year earlier, with the FY2025 full-year figure at $454.5 million, up 28.2% from the prior year.
• Total Liabilities grew to $454.5 million in Q4 2025 per CLBT's latest filing, from $386.6 million in the prior quarter.
• Across five years, Total Liabilities topped out at $596.7 million in Q2 2024 and bottomed at $293.0 million in Q3 2022.
• The 5-year median for Total Liabilities is $382.8 million (2025), against an average of $402.4 million.
• Across the five-year window, Total Liabilities soared 107.21% in 2021 and slumped 37.68% in 2025, its largest moves.
• Year by year, Total Liabilities stood at $413.1 million in 2021, then declined by 20.26% to $329.4 million in 2022, then soared by 51.38% to $498.7 million in 2023, then decreased by 28.9% to $354.5 million in 2024, then increased by 28.2% to $454.5 million in 2025.
• Per Business Quant, the three latest CLBT Total Liabilities figures stand at $454.5 million (Q4 2025), $386.6 million (Q3 2025), and $379.0 million (Q2 2025).